#news #biotech Bristol-backed Cardior gets $75M to run midphase antisense heart failure trial

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Bristol-backed Cardior gets $75M to run midphase antisense heart failure trial .Bristol-backed Cardior gets $75M to run midphase antisense heart failure trial
ntaylor
Wed, 08/25/2021 – 08:05

from FierceBiotech: Biotech https://ift.tt/3B84zOI